Balance Sheet

Current Liabilities	841.3m
Accounts Payable	223.5m
Accrued Liabilities	156.9m
Short-Term Debt	202.5m
Other Current Liabilities	258.4m
Non-Current Liabilities	405m
Long-Term Debt	385.5m
Other Non-Current Liabilities	19.5m

Currency: CNY

	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	64	131	232	474	1 211	488
Cash	1	0	0	474	1 211	488
Cash Equivalents	64	131	232	0	0	0
Short-Term Investments	0	0	0	16	182	220
Total Receivables	170	197	228	276	424	473
Accounts Receivables	154	182	210	245	323	397
Other Receivables	15	16	18	31	101	75
Inventory	204	268	298	364	570	635
Other Current Assets	13	34	35	48	109	36
Total Current Assets	451	630	794	1 178	2 495	1 851
PP&E Net	301	362	451	672	1 044	1 371
PP&E Gross	301	362	451	672	1 044	1 371
Accumulated Depreciation	53	94	155	244	382	530
Intangible Assets	34	33	36	105	217	201
Goodwill	0	0	0	0	5	5
Note Receivable	6	5	4	4	0	0
Long-Term Investments	0	0	0	75	319	277
Other Long-Term Assets	47	45	39	103	132	100
Other Assets	0	0	0	0	5	5
Total Assets	838 N/A	1 076 +28%	1 323 +23%	2 138 +62%	4 212 +97%	3 806 -10%
Liabilities
Accounts Payable	116	70	78	142	321	223
Accrued Liabilities	28	43	43	61	265	157
Short-Term Debt	97	149	306	172	304	202
Current Portion of Long-Term Debt	29	56	5	5	5	1
Other Current Liabilities	87	62	89	133	639	257
Total Current Liabilities	356	379	521	512	1 534	841
Long-Term Debt	123	88	8	78	189	385
Deferred Income Tax	0	0	0	0	14	9
Minority Interest	0	1	4	11	28	26
Other Liabilities	26	31	31	33	30	37
Total Liabilities	506 N/A	496 -2%	556 +12%	612 +10%	1 795 +193%	1 246 -31%
Equity
Common Stock	100	364	364	405	567	568
Retained Earnings	100	202	391	596	1 446	1 546
Additional Paid In Capital	133	13	13	525	390	432
Other Equity	0	0	1	0	14	14
Total Equity	333 N/A	579 +74%	768 +33%	1 526 +99%	2 417 +58%	2 560 +6%
Total Liabilities & Equity	838 N/A	1 076 +28%	1 323 +23%	2 138 +62%	4 212 +97%	3 806 -10%
Shares Outstanding
Common Shares Outstanding	100	364	364	567	567	568

Shenzhen YHLO Biotech Co Ltd
SSE:688575